Feb 4 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES SUBMISSION OF ORPHAN DRUG DESIGNATION APPLICATION TO THE FDA
Feb 4 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX ANNOUNCES SUBMISSION OF ORPHAN DRUG DESIGNATION APPLICATION TO THE FDA